Ketamine-associated corneal edema

Cornea

Volumn 31, Issue 5, 2012, Pages 572-574

  Starte, Julia Mary ^a   Tien Chin Fung, Adrian ^a,b   Kerdraon, Yves Axel ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SYDNEY EYE HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

corneal edema; drug induced ocular toxicity; ketamine; pachymetry

Indexed keywords

ATORVASTATIN; DIAZEPAM; EZETIMIBE; FLECAINIDE ACETATE; FUROSEMIDE; KETAMINE; PHENELZINE; TAMSULOSIN;

ADULT; ARTICLE; CASE REPORT; CELL COUNT; CELL LOSS; CONFOCAL MICROSCOPY; CONGENITAL CORNEA DYSTROPHY; CORNEA EDEMA; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ENDOTHELIUM CELL; EPIPHORA; GRAFT FAILURE; HUMAN; IN VIVO STUDY; INTRAOCULAR PRESSURE; KERATOPLASTY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; VISUAL ACUITY;

CORNEAL EDEMA; ENDOTHELIUM, CORNEAL; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; MALE; MIDDLE AGED; VISUAL ACUITY;

EID: 84859978166     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31823f8af4     Document Type: Article

References (9)

1. Rossi S, ed. Australian Medicines Handbook. Adelaide, Australia: Australian Medicines Handbook Pty Ltd; 2010.
2. Maeng S, Zarate CA Jr. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep. 2007;9:467-474. (Pubitemid 350284937)
3. National Registry of Drug-Induced Ocular Side Effects. Available at: http://www.eyedrugregistry.com/index.cfm?fuseaction=member. dspAboutRegistryLayout. Accessed May 10, 2010.
4. Tita B, Leone MG, Casini ML, et al. Corneal toxicity of xylazine and clonidine, in combination with ketamine, in the rat. Ophthalmic Res. 2001; 33:345-352. (Pubitemid 34015799)
5. Chang KC, Jeong JH, Kim MK, et al. The effect of amantadine on corneal endothelium in subjects with Parkinson's disease. Ophthalmology. 2010; 117:1214-1219.
6. Jeng BH, Galor A, Lee MS, et al. Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology. 2008;115:1540-1544.
7. French DD, Margo CE. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. Cornea. 2007;26:1087-1089. (Pubitemid 47480691)
8. Shippy S, Pulido JS, Qian H, et al. Evidence for corneal glutamate receptor expression and function [Poster]. Trans Am Ophthalmol Soc. 2007; 105:249-251. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258110/.
9. Jun AS. One hundred years of Fuchs' dystrophy. Ophthalmology. 2010; 117:859-860.